Form 4 for KNSA Kiniksa Pharmaceuticals International, plc
Accepted 2025-09-03 00:00:00 ET · period of report 2025-09-01 · accession 0001415889-25-023587 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-09-03 | 2025-09-01+ | KNSA | Tessari Eben | COO | F - Tax | $33.68 | -3,972 | 43.4K | -8% | -$133.8K |
| DM | 2025-09-03 | 2025-09-01+ | KNSA | Tessari Eben | COO | M - OptEx | $15.50 | +23.3K | 43.7K | +114% | +$361.2K |
| D | 2025-09-03 | 2025-09-03 | KNSA | Tessari Eben | COO | S - Sale+OE | $35.50 | -15.1K | 44.5K | -25% | -$535.7K |
| DM | 2025-09-03 | 2025-09-01+ | KNSA | Tessari Eben | COO | M - OptEx | $0.00 | -19.8K | 0 | -100% | $0 |
| DM | 2025-09-03 | 2025-09-01 | KNSA | Tessari Eben | COO | A - Grant | $0.00 | +49.2K | 9,828 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Ordinary Share | 2025-09-02 | F | D | 950 | $34.28 | 44,452 | D | — | — | |
| 2 | Common | Class A Ordinary Share | 2025-09-03 | M | A | 65 | $15.52 | 44,517 | D | — | — | |
| 3 | Common | Class A Ordinary Share | 2025-09-03 | M | A | 15,026 | $15.50 | 59,543 | D | — | — | |
| 4 | Common | Class A Ordinary Share | 2025-09-03 | S | D | 15,091 | $35.50 | 44,452 | D | — | — | (F3) This transaction was executed in multiple trades through a broker-dealer at prices ranging between $35.50 and $35.53. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. |
| 5 | Common | Class A Ordinary Share | 2025-09-02 | M | A | 1,964 | — | 45,402 | D | — | — | (F1) Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer. |
| 6 | Common | Class A Ordinary Share | 2025-09-01 | F | D | 3,022 | $33.49 | 43,438 | D | — | — | |
| 7 | Common | Class A Ordinary Share | 2025-09-01 | M | A | 2,726 | — | 46,460 | D | — | — | (F1) Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer. |
| 8 | Common | Class A Ordinary Share | 2025-09-01 | M | A | 1,746 | — | 41,961 | D | — | — | (F1) Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer. |
| 9 | Common | Class A Ordinary Share | 2025-09-01 | M | A | 1,773 | — | 43,734 | D | — | — | (F1) Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer. |
| 10 | Derivative | Restricted Share Unit | 2025-09-01 | M | D | 2,726 | $0.00 | 2,726 | D | — · — to — | 2,726 Class A Ordinary Share | (F1) Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer. (F8) The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 1, 2022. |
| 11 | Derivative | Share Option | 2025-09-03 | M | D | 65 | $0.00 | 59,935 | D | $15.52 · — to 2030-03-12 | 65 Class A Ordinary Share | (F10) The option is fully vested and exercisable. |
| 12 | Derivative | Share Option | 2025-09-03 | M | D | 15,026 | $0.00 | 44,974 | D | $15.50 · — to 2030-09-09 | 15,026 Class A Ordinary Share | (F10) The option is fully vested and exercisable. |
| 13 | Derivative | Restricted Share Unit | 2025-09-01 | M | D | 1,773 | $0.00 | 3,545 | D | — · — to — | 1,773 Class A Ordinary Share | (F1) Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer. (F7) The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 1, 2023. |
| 14 | Derivative | Restricted Share Unit | 2025-09-01 | M | A | 1,746 | $0.00 | 5,235 | D | — · — to — | 1,746 Class A Ordinary Share | (F1) Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer. (F6) The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the grant date September 1, 2024. |
| 15 | Derivative | Share Option | 2025-09-01 | A | A | 39,364 | $0.00 | 39,364 | D | $33.49 · — to 2035-08-31 | 39,364 Class A Ordinary Share | (F5) The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in 36 equal monthly installments thereafter. The vesting commencement date is September 1, 2025. |
| 16 | Derivative | Restricted Share Unit | 2025-09-01 | A | A | 9,828 | $0.00 | 9,828 | D | — · — to — | 9,828 Class A Ordinary Share | (F1) Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer. (F4) The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the grant date September 1, 2025. |
| 17 | Derivative | Restricted Share Unit | 2025-09-02 | M | D | 1,964 | $0.00 | 0 | D | — · — to — | 1,964 Class A Ordinary Share | (F1) Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer. (F9) The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the vesting commencement date September 2, 2021. |